← Back to Search

Nutritional Supplement

Enriched Eggs for Diabetic Retinopathy

N/A
Recruiting
Led By Miyoung Suh, RD, PhD
Research Sponsored by University of Manitoba
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Individuals with a fasting plasma glucose of ≥7.0 mmol/L or glycated hemoglobin (A1C) of ≥6.5% (these values are based on the Canadian Diabetes Association and are predictors of the development of diabetic retinopathy)
Individuals taking oral hypoglycemic medications (sulfonylureas, meglitinides, biguanides, thiazolidinediones etc.)
Must not have
Individuals taking insulin
Individuals with eye disease (cataracts, glaucoma, age-related macular degeneration, retinitis pigmentosa, optic atrophy, and eye malformation etc.)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 weeks
Awards & highlights

Summary

This trialaims to assess if eating two DHA & lutein enriched eggs a day can improve eye health in those with diabetes, without impacting body composition & cardiovascular risk.

Who is the study for?
This trial is for adults over 19 with Type 2 diabetes who have a fasting plasma glucose of ≥7.0 mmol/L or A1C of ≥6.5%, and are taking oral hypoglycemic medications. It's not for those with cognitive diseases, eye diseases other than diabetic retinopathy, severe diabetic retinopathy, insulin users, cancer or anemia patients, or pregnant women.
What is being tested?
The study tests if eating two DHA and lutein enriched eggs daily improves retina health in Type 2 diabetics compared to regular eggs. This double-blinded trial will measure changes in blood lipids, carotenoids, body composition and cardiovascular risk factors after six weeks.
What are the potential side effects?
Potential side effects may include changes to cholesterol levels due to egg consumption; however specific side effects related to the enriched eggs aren't detailed but could be similar to regular egg consumption.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My blood sugar or A1C levels indicate I might develop diabetic eye disease.
Select...
I am taking oral medication for diabetes.
Select...
I have been diagnosed with Type 2 diabetes.
Select...
I am over 19 years old.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am currently taking insulin.
Select...
I have an eye condition like cataracts or glaucoma.
Select...
I have been diagnosed with moderate to severe diabetic retinopathy.
Select...
I have been diagnosed with cancer or anemia.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in Retina Function

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Enriched Egg GroupExperimental Treatment1 Intervention
Participants will consume 2 medium sized docosahexaenoic acid and lutein enriched eggs daily (at least 5 days per week) for 6 weeks.
Group II: Regular Egg GroupPlacebo Group1 Intervention
Participants will consume 2 medium sized non-enriched eggs daily (at least 5 days per week) for 6 weeks.

Find a Location

Who is running the clinical trial?

University of ManitobaLead Sponsor
612 Previous Clinical Trials
201,494 Total Patients Enrolled
Egg Farmers of CanadaUNKNOWN
2 Previous Clinical Trials
205 Total Patients Enrolled
Miyoung Suh, RD, PhDPrincipal InvestigatorUniversity of Manitoba
~19 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top